Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 2, Issue 9, pp. 792-799
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 19, 2008
- Revision received June 21, 2009
- Accepted July 14, 2009
- Published first September 8, 2009.
Article Versions
- Previous version (September 8, 2009 - 09:56).
- You are viewing the most recent version of this article.
Copyright & Usage
©2009 American Association for Cancer Research.
Author Information
- Iris L. Romero1,
- Ilyssa O. Gordon2,
- Sujatha Jagadeeswaran1,
- Keeley L. Mui1,
- Woo Seok Lee1,
- Daniela M. Dinulescu3,
- Thomas N. Krausz2,
- Helen H. Kim1,
- Melissa L. Gilliam1, and
- Ernst Lengyel1
- Authors' Affiliations: 1Department of Obstetrics and Gynecology-Center for Integrative Science and 2Department of Pathology, University of Chicago, Chicago, Illinois and 3Brigham Women's Hospital, Harvard Medical School, Boston, Massachusetts
- Requests for reprints:
Ernst Lengyel, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago, MC 2050, 5841 South Maryland Avenue, Chicago, IL 60637. Phone: 773-702-6722; Fax: 773-702-5411; E-mail: elengyel{at}uchicago.edu.
September 2009
Volume 2, Issue 9
Volume 2, Issue 9
Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice
Jump to section
Advertisement